HCP Investments disclosed disposal of 6.5M shares (7.5% stake) in Ind-Swift Laboratories via open market sales from April 13-17, 2026.
The transaction reduces HCP's holding from 8.649% to 1.149% of Ind-Swift's total paid-up share capital.
Disclosure made under SEBI Regulation 29(2) of Substantial Acquisition of Shares and Takeover Regulations, 2011.
Company Secretary Pardeep Verma submitted the intimation to BSE and NSE on April 22, 2026.